Chemical synthesis of the ATAD2 bromodomain

被引:14
|
作者
Creech, Gardner S. [1 ]
Paresi, Chelsea [2 ,3 ]
Li, Yue-Ming [2 ,3 ]
Danishefsky, Samuel J. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Bioorgan Chem Lab, New York, NY 10065 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Dept Pharmacol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA
[4] Columbia Univ, Dept Chem, New York, NY 10027 USA
基金
美国国家卫生研究院;
关键词
solid-phase peptide synthesis; desulfurization; peptide retrosynthesis; ANDROGEN RECEPTOR; COREGULATOR ANCCA; LIGATION; COACTIVATOR; PROTEINS; BREAST; CANCER; GENES; IDENTIFICATION; PEPTIDES;
D O I
10.1073/pnas.1400556111
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Due to the emerging importance of the bromodomain binding region in the study of epigenetic effectors and the vast implications for a wide variety of human disease, the bromodomain region of human ATPase family AAA+ (ATPases associated with diverse cellular activities) domain-containing protein 2 (ATAD2) was targeted for chemical synthesis. The ATAD2 bromodomain (130 aa) was divided into five strategic fragments to be assembled using native chemical ligation with a focus on maximal convergency and efficiency. The fragments were assembled with one cysteine and three thioleucine ligations, unveiling the native alanine and leucine amino acids at the ligation points following metal-free dethiylation. Synthetic highlights of the study are a photolabile dimethoxynitrobenzyl-protected glutamic acid side chain used to impede hydrolysis of the C-terminal Glu-thioester, a thiazolidine-protected thioleucine, and an efficient assembly of three fragments in a single reaction vessel with dual-mode kinetic-standard chemical ligation. With a focus on material throughput and convergency, the five peptide fragments were assembled into the native ATAD2 bromodomain region with a total of three HPLC events in 8% overall yield from the fragments.
引用
收藏
页码:2891 / 2896
页数:6
相关论文
共 50 条
  • [31] ATAD2 in cancer: a pharmacologically challenging but tractable target
    Hussain, Muzammal
    Zhou, Yang
    Song, Yu
    Hameed, H. M. Adnan
    Jiang, Hao
    Tu, Yaoquan
    Zhang, Jiancun
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (01) : 85 - 96
  • [32] ATAD2 is associated with malignant characteristics of pancreatic cancer cells
    Liu, Nairong
    Funasaka, Kohei
    Obayashi, Tomohiko
    Miyahara, Ryoji
    Hirooka, Yoshiki
    Goto, Hidemi
    Senga, Takeshi
    [J]. ONCOLOGY LETTERS, 2019, 17 (03) : 3489 - 3494
  • [33] Oncogenic potential of ATAD2 in stomach cancer and insights into the protein-protein interactions at its AAA plus ATPase domain and bromodomain
    Nayak, Aditi
    Kumar, Sugandh
    Singh, Shivaram Prasad
    Bhattacharyya, Asima
    Dixit, Anshuman
    Roychowdhury, Anasuya
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (12): : 5606 - 5622
  • [34] Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains
    Phillips, Margaret
    Malone, Kiera L.
    Boyle, Brian W.
    Montgomery, Cameron
    Kressy, Isabelle A.
    Joseph, Faith M.
    Bright, Kathleen M.
    Boyson, Samuel P.
    Chang, Sunsik
    Nix, Jay C.
    Young, Nicolas L.
    Jeffers, Victoria
    Frietze, Seth
    Glass, Karen C.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (10) : 8186 - 8200
  • [35] Tumor-Promoting ATAD2 and Its Preclinical Challenges
    Liu, Haicheng
    Wen, Qianghai
    Yan, Sheng
    Zeng, Weikun
    Zou, Yuhua
    Liu, Quanliang
    Zhang, Guoxi
    Zou, Junrong
    Zou, Xiaofeng
    [J]. BIOMOLECULES, 2022, 12 (08)
  • [36] ATAD2 overexpression is associated with progression and prognosis in colorectal cancer
    Hou, Mingming
    Huang, Rui
    Song, Yanni
    Feng, Di
    Jiang, Yang
    Liu, Ming
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (03) : 222 - 227
  • [37] Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives
    Nayak, Aditi
    Dutta, Madhuri
    Roychowdhury, Anasuya
    [J]. LIFE SCIENCES, 2021, 276
  • [38] ARID1A regulation of ATAD2 in gynecologic cancer
    Shoji, Yutaka
    Conrads, Kelly A.
    Challa, Rusheeswar
    Hood, Brian L.
    Wang, Guisong
    Darcy, Kathleen M.
    Hamilton, Chad A.
    Maxwell, George Larry
    Conrads, Thomas P.
    Risinger, John I.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [39] ATAD2 controls chromatin-bound HIRA turnover
    Wang, Tao
    Perazza, Daniel
    Boussouar, Faycal
    Cattaneo, Matteo
    Bougdour, Alexandre
    Chuffart, Florent
    Barral, Sophie
    Vargas, Alexandra
    Liakopoulou, Ariadni
    Puthier, Denis
    Bargier, Lisa
    Morozumi, Yuichi
    Jamshidikia, Mahya
    Garcia-Saez, Isabel
    Petosa, Carlo
    Rousseaux, Sophie
    Verdel, Andre
    Khochbin, Saadi
    [J]. LIFE SCIENCE ALLIANCE, 2021, 4 (12)
  • [40] Molecular docking and QSAR analysis of naphthyridone derivatives as ATAD2 bromodomain inhibitors: application of CoMFA, LS-SVM, and RBF neural network
    Sepehri, Bakhtyar
    Rasouli, Zolaikha
    Hassanzadeh, Zeinabe
    Ghavami, Raouf
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (12) : 2895 - 2905